Euroapi (FRA:940) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


FRA:940 Euroapi SA FRA:940
61 GF Score
Price €1.31
GF Value €2.91
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Euroapi Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Euroapi's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

FRA:940 vs ZTS, UTHR, VTRS: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Euroapi's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Euroapi Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Euroapi's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Euroapi's Margin of Safety % (DCF Earnings Based) falls into.


FRA:940
61GF Score
Euroapi SA FRA:940
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Euroapi (FRA:940) Overvalued in 2026?

Based on GuruFocus' analysis, Euroapi stock appears to be undervalued. The current stock price of €1.31 is trading 55% below its estimated GF Value™ of €2.91. GuruFocus considers Euroapi to be Possible Value Trap.

Key valuation signals for FRA:940:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €2.91 vs. price of €1.31 (55% below fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the FRA:940 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Euroapi Business Description

Address 32 rue Alexandre Duma, Paris, FRA, 75011
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates, analgesics, and others. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers.
61GF Score

Get the complete analysis for FRA:940

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.31
Price
€2.91
GF Value